Motley Fool Asset Management LLC
Source: SEC Form 13F · as of Mar 2026Motley Fool Asset Management LLC holds 23 biotech & pharma companies tracked by BioSniper, totaling $83.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$83.7M
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 112,527 | $15.7M |
| AMGNAMGEN INC | 43,815 | $15.4M |
| BMYBRISTOL MYERS SQUIBB CO | 176,588 | $10.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 20,302 | $9.1M |
| MCKMcKesson Corporation | 9,959 | $8.6M |
| WSTWest Pharmaceutical Services Inc. | 18,074 | $4.5M |
| IDXXIDEXX LABORATORIES INC /DE | 7,822 | $4.4M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 10,492 | $3.5M |
| ICLRICON plc | 28,938 | $3.2M |
| GEHCGE HealthCare Technologies Inc. | 37,252 | $2.7M |
| RAREUltragenyx Pharmaceutical Inc. | 78,141 | $1.6M |
| ADMAADMA BIOLOGICS, INC. | 100,694 | $907K |
| BIIBBIOGEN INC. | 2,919 | $535K |
| INCYIncyte Corp. | 5,496 | $517K |
| MEDPMedpace Holdings Inc. | 893 | $429K |
| DGXQuest Diagnostics Incorporated | 1,755 | $344K |
| MRNAModerna, Inc. | 6,527 | $332K |
| BBIOBridgeBio Pharma, Inc. | 4,041 | $300K |
| NBIXNEUROCRINE BIOSCIENCES INC | 1,852 | $244K |
| GHGuardant Health Inc. | 2,596 | $240K |
| GMEDGlobus Medical Inc. | 2,637 | $227K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 3,952 | $223K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 11,845 | $42K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.